Dec 30, 2024 07:00AM
Dec 30, 2024 07:00AM
Nov 12, 2024 04:00PM
Oct 24, 2024 08:01AM
Oct 24, 2024 08:00AM
Oct 17, 2024 07:00AM
Oct 17, 2024 07:00AM Marinus Pharmaceuticals Presents Clinical Data From Pivotal Phase 3 RAISE Trial in Refractory Status Epilepticus at the Neurocritical Care Society 2024 Annual Meeting
Oct 15, 2024 04:01PM
Oct 15, 2024 04:00PM
Oct 9, 2024 07:00AM
Oct 8, 2024 04:04PM
Sep 20, 2024 08:03AM
Sep 20, 2024 08:00AM
Sep 12, 2024 08:00AM Marinus Pharmaceuticals Announces Agenda and Speakers for Investor & Analyst Day on September 20, 2024
Sep 10, 2024 08:00AM
Aug 19, 2024 08:00AM
Aug 13, 2024 07:00AM
Aug 6, 2024 04:01PM
Jul 30, 2024 08:00AM
Jul 18, 2024 07:01AM
Jul 18, 2024 07:00AM Marinus Pharmaceuticals Announces Ganaxolone Approved in China as First Treatment for Seizures Associated with CDKL5 Deficiency Disorder
Jun 17, 2024 07:00AM
Jun 17, 2024 07:00AM
May 17, 2024 07:00AM
May 17, 2024 07:00AM
May 8, 2024 07:00AM
May 2, 2024 08:00AM
May 1, 2024 08:00AM Marinus Pharmaceuticals to Provide Business Update and Report First Quarter 2024 Financial Results on May 8, 2024
Apr 15, 2024 07:01AM
Apr 15, 2024 07:00AM
Apr 5, 2024 04:00PM
Mar 27, 2024 08:41AM
Mar 27, 2024 08:41AM
Mar 19, 2024 04:15PM
Mar 5, 2024 04:01PM Marinus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
Feb 21, 2024 07:00AM
Feb 20, 2024 07:00AM
Feb 16, 2024 04:00PM
Jan 22, 2024 08:23AM
Jan 4, 2024 04:30PM
Jan 4, 2024 07:07AM
Jan 4, 2024 07:01AM Marinus Pharmaceuticals Reports Preliminary Fourth Quarter and Full Year 2023 ZTALMY® Net Product Revenue and Provides Business Update
Dec 7, 2023 04:30PM
Nov 20, 2023 04:01PM
Nov 14, 2023 04:05PM
Nov 9, 2023 04:30PM
Nov 7, 2023 07:03AM
Nov 7, 2023 07:01AM
Nov 7, 2023 07:00AM Marinus Pharmaceuticals Initiates Global Access Program for ZTALMY® (ganaxolone) Oral Suspension CV
Oct 24, 2023 07:01AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All